Review of efficacy and safety of duloxetine 40 to 60 mg once daily in patients with diabetic peripheral neuropathic pain

Pain Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Skljarevski, Vladimir ^a   Frakes, Elijah P ^a   Sagman, Doron ^b   Lipsius, Sarah ^b   Heinloth, Alexandra N ^b   Dueñas Tentori, Héctor J ^b  

^a ELI LILLY AND COMPANY   (United States)

^b Department of Neuroscience Eli Lilly Canada ^*  (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873863620     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2012/898347     Document Type: Review

References (27)

1. Chen L., Magliano D. J., Zimmet P. Z., The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nature Reviews Endocrinology 2012 8 4 228 236 2-s2.0-84858702540 10.1038/nrendo.2011.183
2. Danaei G., Finucane M. M., Lu Y., Singh G. M., Cowan M. J., Paciorek C. J., Lin J. K., Farzadfar F., Khang Y. H., Stevens G. A., Rao M., Ali M. K., Riley L. M., Robinson C. A., Ezzati M., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2 · 7 million participants. The Lancet 2011 378 9785 31 40 2-s2.0-79959936188 10.1016/S0140-6736(11)60679-X
3. Chan J. C. N., Chan S. P., Deerochanawong C., Go R. T., Lee K. O., Ma R. C. W., Pan C. Y., Sheu W. H. H., Barter P., Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: what we know and don't know. Diabetes Research and Clinical Practice 2011 94 1 1 13 2-s2.0-79960010605 10.1016/j.diabres.2011.05.034
4. Barrett A. M., Lucero M. A., Le T., Robinson R. L., Dworkin R. H., Chappell A. S., Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Medicine 2007 8 2 S50 S62 2-s2.0-34548094313 10.1111/j.1526-4637.2006.00179.x (Pubitemid 47288511)
5. Sadosky A., McDermott A. M., Brandenburg N. A., Strauss M., A Review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Practice 2008 8 1 45 56 2-s2.0-38349103076 10.1111/j.1533-2500.2007.00164.x
6. Fuller R. W., Hemrick-Luecke S. K., Snoddy H. D., Effects of duloxetine, an antidepressant drug candidate on concentrations of monoamines and their metabolites in rats and mice. Journal of Pharmacology and Experimental Therapeutics 1994 269 1 132 136 2-s2.0-0028326399 (Pubitemid 24143244)
7. Wong D. T., Bymaster F. P., Mayle D. A., Reid L. R., Krushinski J. H., Robertson D. W., LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology 1993 8 1 23 33 2-s2.0-0027475388 (Pubitemid 23011155)
8. Perahia D. G. S., Pritchett Y. L., Desaiah D., Raskin J., Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? International Clinical Psychopharmacology 2006 21 6 311 317 2-s2.0-33749315762 10.1097/01.yic.0000224782.83287.3c (Pubitemid 44498273)
9. Bymaster F. P., Lee T. C., Knadler M. P., Detke M. J., Iyengar S., The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Current Pharmaceutical Design 2005 11 12 1475 1493 2-s2.0-18844370877 10.2174/1381612053764805 (Pubitemid 40691447)
10. Fields H. L., Heinricher M. M., Mason P., Neurotransmitters in nociceptive modulatory circuits. Annual Review of Neuroscience 1991 14 219 245 2-s2.0-0025959669
11. Robinson M. J., Edwards S. E., Iyengar S., Bymaster F., Clark M., Katon W., Depression and pain. Frontiers in Bioscience 2009 14 13 5031 5051 2-s2.0-69149096257 10.2741/3585
12. Cymbalta, Package Insert 2011 Indianapolis, Ind, USA Eli Lilly and Company
13. Goldstein D. J., Lu Y., Detke M. J., Lee T. C., Iyengar S., Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005 116 1-2 109 118 2-s2.0-20444464304 10.1016/j.pain.2005.03.029 (Pubitemid 40828506)
14. Wernicke J. F., Pritchett Y. L., D'Souza D. N., Waninger A., Tran P., Iyengar S., Raskin J., A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006 67 8 1411 1420 2-s2.0-33750341692 10.1212/01.wnl.0000240225.04000.1a (Pubitemid 44632065)
15. Raskin J., Pritchett Y. L., Wang F., D'Souza D. N., Waninger A. L., Iyengar S., Wernicke J. F., A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Medicine 2005 6 5 346 356 2-s2.0-28444459170 10.1111/j.1526-4637.2005.00061.x (Pubitemid 41727332)
16. Eli Lilly and Company, HMFX: a study for the treatment of diabetic peripheral neuropathic pain. ClinicalTrials.gov 2010 Bethesda, Md, USA National Library of Medicine. http://www.clinicaltrials.gov/ct2/show/results/NCT00552175? term=HMFX&rank=1
17. Skljarevski V., Desaiah D., Zhang Q., Chappell A. S., Detke M. J., Gross J. L., Ziegler D., Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. Diabetes/Metabolism Research and Reviews 2009 25 7 623 631 2-s2.0-70350604295 10.1002/dmrr.1000
18. Yasuda H., Hotta N., Nakao K., Kasuga M., Kashiwagi A., Kawamori R., Superiority of duloxetine to placebo in improving diabetic neuropathic pain: results of a randomized controlled trial in Japan. Journal of Diabetes Investigation 2011 2 2 132 139 2-s2.0-79961092686 10.1111/j.2040-1124.2010. 00073.x
19. Kajdasz D. K., Iyengar S., Desaiah D., Backonja M. M., Farrar J. T., Fishbain D. A., Jensen T. S., Rowbotham M. C., Sang C. N., Ziegler D., McQuay H. J., Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clinical Therapeutics 2007 29 11 2536 2546 2-s2.0-37349086775 10.1016/j.clinthera.2007.12.002 (Pubitemid 350299457)
20. Eli Lilly and Company, Data on file. 2011
21. Wasan A. D., Ossanna M. J., Raskin J., Wernicke J. F., Robinson M. J., Hall J. A., Edwards S. E., Lipsius S., Meyers A. L., McCarberg B. H., Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients. Current Drug Safety 2009 4 1 22 29 2-s2.0-63249098506 10.2174/157488609787354404
22. Armstrong D. G., Chappell A. S., Le T. K., Kajdasz D. K., Backonja M., D'Souza D. N., Russell J. M., Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes. Pain Medicine 2007 8 5 410 418 2-s2.0-34547432986 10.1111/j.1526-4637.2007.00276.x (Pubitemid 47163278)
23. Dworkin R. H., Turk D. C., Wyrwich K. W., Beaton D., Cleeland C. S., Farrar J. T., Haythornthwaite J. A., Jensen M. P., Kerns R. D., Ader D. N., Brandenburg N., Burke L. B., Cella D., Chandler J., Cowan P., Dimitrova R., Dionne R., Hertz S., Jadad A. R., Katz N. P., Kehlet H., Kramer L. D., Manning D. C., McCormick C., McDermott M. P., McQuay H. J., Patel S., Porter L., Quessy S., Rappaport B. A., Rauschkolb C., Revicki D. A., Rothman M., Schmader K. E., Stacey B. R., Stauffer J. W., von Stein T., White R. E., Witter J., Zavisic S., Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008 9 2 105 121 2-s2.0-38549181857 10.1016/j.jpain.2007.09.005 (Pubitemid 351147828)
24. Eli Lilly and Company, HMEM: maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain (DPNP). ClinicalTrials.gov 2010 Bethesda, Md, USA National Library of Medicine. http://www.clinicaltrials. gov/ct2/show/NCT00322621?term=HMEM&rank=1
25. Yan G., Guang N., Wei-Ping J., Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China. Chinese Medical Journal 2010 123 22 3184 3192 2-s2.0-79251486666 10.3760/cma.j.issn.0366-6999.2010.22. 003
26. McIntyre R. S., Soczynska J. K., Konarski J. Z., Kennedy S. H., The effect of antidepressants on glucose homeostatis and insulin sensitivity: synthesis and mechanisms. Expert Opinion on Drug Safety 2006 5 1 157 168 2-s2.0-30344449725 10.1517/14740338.5.1.157 (Pubitemid 43056447)
27. Gahimer J., Wernicke J., Yalcin I., Ossanna M. J., Wulster-Radcliffe M., Viktrup L., A retrospective pooled analysis of duloxetine safety in 23 983 subjects. Current Medical Research and Opinion 2007 23 1 175 184 2-s2.0-33846669702 10.1185/030079906X162719 (Pubitemid 46191681)